Increased Circulating Immunosuppressive CD14+HLA-DR−/Low Cells Correlate with Clinical Cancer Stage and Pathological Grade in Patients with Bladder Carcinoma

Autor: Zhu X, Xiao P, Yuncheng Xia, Xiaokun Zhao, Yuan Xk

Publikováno v: Journal of International Medical Research. 39:1381-1391

This study investigated CD14+HLA-DR−/low cells in peripheral blood mononuclear cells (PBMCs) from 64 patients with bladder carcinoma (BC) and 14 healthy controls. Cell phenotypes were determined and CD14+HLA-DR−/low cells, CD14+HLA-DR+ cells and

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1302e31fd25d4fea49c5e6d8ef1bcdb0
https://doi.org/10.1177/147323001103900424

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Microbial metabolite-guided CAR T cell engineering enhances anti-tumor immunity via epigenetic-metabolic crosstalk.

Autor: Staudt S; Lehrstuhl für Zelluläre Immuntherapie, Medizinische Klinik und Poliklinik II, Universitätsklinikum Würzburg, Würzburg, Germany., Nikolka F; Department of Bioinformatics and Biochemistry, Braunschweig Integrated Centre of Systems Biology (BRICS), Technische Universität Braunschweig, Braunschweig, Germany., Perl M; University Hospital Regensburg, Department of Internal Medicine III, Hematology & Internal Oncology, Regensburg, Germany., Franz J; Lehrstuhl für Zelluläre Immuntherapie, Medizinische Klinik und Poliklinik II, Universitätsklinikum Würzburg, Würzburg, Germany., Leblay N; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, Alberta, Canada., Yuan XK; Precision Oncology Hub, Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, Alberta, Canada., Warmuth L; Institute for Medical Microbiology, Immunology and Hygiene, Technical University of Munich, Munich, Germany., Fantes MA; University Hospital Regensburg, Department of Internal Medicine III, Hematology & Internal Oncology, Regensburg, Germany., Skorupskaitė A; Life Sciences Center - European Molecular Biology Laboratory (LSC-EMBL) Partnership for Genome Editing Technologies, Vilnius University - Life Sciences Center, Vilnius University, Vilnius, Lithuania., Fei T; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York., Bromberg M; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York., Martin-Uriz PS; Hemato-Oncology Program, Cima Universidad de Navarra, Centro de Investigacion Biomedica en Red de Cancer (CIBERONC), Cancer Center Clinica Universidad de Navarra (CCUN), IdiSNA, Pamplona, Spain., Rodriguez-Madoz JR; Hemato-Oncology Program, Cima Universidad de Navarra, Centro de Investigacion Biomedica en Red de Cancer (CIBERONC), Cancer Center Clinica Universidad de Navarra (CCUN), IdiSNA, Pamplona, Spain., Ziegler-Martin K; Lehrstuhl für Zelluläre Immuntherapie, Medizinische Klinik und Poliklinik II, Universitätsklinikum Würzburg, Würzburg, Germany., Gholam NA; Lehrstuhl für Zelluläre Immuntherapie, Medizinische Klinik und Poliklinik II, Universitätsklinikum Würzburg, Würzburg, Germany., Benz P; Lehrstuhl für Zelluläre Immuntherapie, Medizinische Klinik und Poliklinik II, Universitätsklinikum Würzburg, Würzburg, Germany., Tran PH; Medical University of Vienna, Center for Pathophysiology, Infectiology and Immunology, Institute of Immunology, Vienna, Austria., Freitag F; Lehrstuhl für Zelluläre Immuntherapie, Medizinische Klinik und Poliklinik II, Universitätsklinikum Würzburg, Würzburg, Germany., Riester Z; Lehrstuhl für Zelluläre Immuntherapie, Medizinische Klinik und Poliklinik II, Universitätsklinikum Würzburg, Würzburg, Germany.; Mildred Scheel Early Career Center, University Hospital of Würzburg, Würzburg, Germany., Stein-Thoeringer C; Innere Medizin I, Universitätsklinikum Tübingen & M3 Research Center, Universitätsklinikum Tübingen., Schmitt M; Department of Hematology, Oncology and Rheumatology, University Clinic Heidelberg, Heidelberg, Germany., Kleigrewe K; Bavarian Center for Biomolecular Mass Spectrometry (BayBioMS), Technical University of Munich, Freising, Germany., Weber J; Lehrstuhl für Zelluläre Immuntherapie, Medizinische Klinik und Poliklinik II, Universitätsklinikum Würzburg, Würzburg, Germany., Mangold K; Lehrstuhl für Zelluläre Immuntherapie, Medizinische Klinik und Poliklinik II, Universitätsklinikum Würzburg, Würzburg, Germany.; Institute for Medical Microbiology and Hygiene, Philipps-University Marburg, Marburg, Germany., Einsele H; Medizinische Klinik und Poliklinik II, Universitätsklinikum Würzburg, Würzburg, Germany., Prosper F; Hematology and Cell Therapy Department, Clinica Universidad de Navarra (CUN), Hemato-Oncology Program, Cima Universidad de Navarra. Centro de Investigacion Biomedica en Red de Cancer (CIBERONC), Cancer Center Clinica Universidad de Navarra (CCUN), IdiSNA, Pamplona, Spain., Ellmeier W; Medical University of Vienna, Center for Pathophysiology, Infectiology and Immunology, Institute of Immunology, Vienna, Austria., Busch D; Institute for Medical Microbiology, Immunology and Hygiene, Technical University of Munich, Munich, Germany., Visekruna A; Institute for Medical Microbiology and Hygiene, Philipps-University Marburg, Marburg, Germany., Slingerland J; City of Hope Comprehensive Cancer Center, Duarte, CA., Shouval R; Adult Bone Marrow Transplantation Service and Cellular Therapy Service, Memorial Sloan Kettering Cancer Center, New York, New York.; Weill Cornell Medical College, New York, New York., Hiller K; Department of Bioinformatics and Biochemistry, Braunschweig Integrated Centre of Systems Biology (BRICS), Technische Universität Braunschweig, Braunschweig, Germany., van den Brink M; City of Hope Comprehensive Cancer Center, Duarte, CA., Pausch P; Life Sciences Center - European Molecular Biology Laboratory (LSC-EMBL) Partnership for Genome Editing Technologies, Vilnius University - Life Sciences Center, Vilnius University, Vilnius, Lithuania., Neri P; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, Alberta, Canada., Hudecek M; Lehrstuhl für Zelluläre Immuntherapie, Medizinische Klinik und Poliklinik II, Universitätsklinikum Würzburg, Würzburg, Germany.; Bavarian Cancer Research Center (BZKF), Regensburg & Würzburg, Germany., Poeck H; University Hospital Regensburg, Department of Internal Medicine III, Hematology & Internal Oncology, Regensburg, Germany.; Bavarian Cancer Research Center (BZKF), Regensburg & Würzburg, Germany.; Leibniz Institute for Immunotherapy (LIT), Regensburg, Germany., Luu M; Lehrstuhl für Zelluläre Immuntherapie, Medizinische Klinik und Poliklinik II, Universitätsklinikum Würzburg, Würzburg, Germany.; Leibniz Institute for Immunotherapy (LIT), Regensburg, Germany.

Publikováno v: BioRxiv : the preprint server for biology [bioRxiv] 2024 Sep 13. Date of Electronic Publication: 2024 Sep 13.

Transcranial ultrasound with electrical stimulation of the cerebello-parietal nucleus on cerebral blood flow and limb function in patients with stroke.

Autor: Liu J; Second Department of Rehabilitation, Second Hospital of Hebei Medical University, NO.215 Heping West Road, Xinhua District, Shijiazhuang, 050000, China.; China Aerospace Science & Industry Corporation  731  Hospital, NO.3 Zhen Gang Nan Li, Yun Gang, Feng Tai District, Beijing, 100074, China., Wang LY; Department of Rehabilitation, Beijing Rehabilitation Hospital, Capital Medical University, Beijing, 100144, China., Liu ZB; Department of Endocrinology, The Second Hospital of Hebei Medical University, Shijiazhuang, 050000, China., Li HL; Second Department of Rehabilitation, Second Hospital of Hebei Medical University, NO.215 Heping West Road, Xinhua District, Shijiazhuang, 050000, China. honglingli_dr06@163.com., Chen YY; Second Department of Rehabilitation, Second Hospital of Hebei Medical University, NO.215 Heping West Road, Xinhua District, Shijiazhuang, 050000, China., Yuan XK; Second Department of Rehabilitation, Second Hospital of Hebei Medical University, NO.215 Heping West Road, Xinhua District, Shijiazhuang, 050000, China., Chi L; Second Department of Rehabilitation, Second Hospital of Hebei Medical University, NO.215 Heping West Road, Xinhua District, Shijiazhuang, 050000, China.

Publikováno v: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology [Neurol Sci] 2024 Aug 01. Date of Electronic Publication: 2024 Aug 01.

Phospholipase A and acyltransferase 4/retinoic acid receptor responder 3 at the intersection of tumor suppression and pathogen restriction.

Autor: Zhao JY; Hospital of Integrated Traditional Chinese and Western Medicine, Hebei University of Chinese Medicine, Cangzhou, Hebei, China., Yuan XK; Hospital of Integrated Traditional Chinese and Western Medicine, Hebei University of Chinese Medicine, Cangzhou, Hebei, China., Luo RZ; Hospital of Integrated Traditional Chinese and Western Medicine, Hebei University of Chinese Medicine, Cangzhou, Hebei, China., Wang LX; Hospital of Integrated Traditional Chinese and Western Medicine, Hebei University of Chinese Medicine, Cangzhou, Hebei, China., Gu W; School of Medicine, Chongqing University, Chongqing, China., Yamane D; Department of Diseases and Infection, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan., Feng H; School of Medicine, Chongqing University, Chongqing, China.

Publikováno v: Frontiers in immunology [Front Immunol] 2023 Mar 31; Vol. 14, pp. 1107239. Date of Electronic Publication: 2023 Mar 31 (Print Publication: 2023).